Articles On Phosphagenics (ASX:POH)

Two dozen esteemed sector figures recently gathered over lunch to recount their career highs and lows One luminary recalls an uncomfortable close encounter with a drug cartel, while others overcame the impact of academic and corporate frau...

The Nasdaq-listed Gelteq has mastered pouch delivery for people who find it difficult to swallow ASX IPO candidate Vaxxas is working on the needle-less delivery of vaccines ASX companies including LTR Pharma and Wellnex Life have devised a...

Highlights Small cap stocks are currently showing a V-shaped recovery from last month’s sell-off. BCK and AVE are two such ASX penny stocks delivering handsome gains to investors today. Investors should not get lured by lucrative retu...

There are many reasons why a company might change its name, from being taken over to hiding a shady past. This year 114 companies have changed their name. Family cyber security provider Wangle Technologies became the much more fitting Famil...

Avecho Biotechnology (ASX:AVE), the company formerly known as Phosphagenics, announced that its Japanese partner is pulling support after three years of research. Avecho has a patented drug delivery system called targeted penetration matrix...

Digital healthcare service has evolved as one of the fastest-growing industries in the modern era. Introduction of technology in medical science has emerged as one of the biggest blessings for human. Digitally connected network systems have...

Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any...

Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any...